In a filing, Incyte Corp revealed its Officer THOMAS R TRAY acquired Company’s shares for reported $42237.0 on Jun 02 ’25. In the deal valued at $64.88 per share,651 shares were bought.
Then, THOMAS R TRAY bought 963 shares, generating $63,279 in total proceeds.
Before that, Flannelly Barry P sold 19,807 shares. Incyte Corp shares valued at $1,340,656 were divested by the EVP & General Manager US at a price of $67.69 per share. As a result of the transaction, Flannelly Barry P now holds 33,567 shares, worth roughly $2.19 million.
William Blair downgraded its Incyte Corp [INCY] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in mid March from “a Buy” to “a Neutral”. UBS began covering INCY with “Neutral” recommendation on December 17, 2024. BofA Securities revised its rating on October 29, 2024. It rated INCY as “a Buy” which previously was an “a Neutral”.
Price Performance Review of INCY
On Monday, Incyte Corp [NASDAQ:INCY] saw its stock jump 0.38% to $65.31. Over the last five days, the stock has gained 1.66%. Incyte Corp shares have fallen nearly -5.44% since the year began. Nevertheless, the stocks have risen 14.74% over the past one year. While a 52-week high of $83.95 was reached on 02/07/25, a 52-week low of $53.56 was recorded on 04/09/25. SMA at 50 days reached $61.07, while 200 days put it at $67.45.
Levels Of Support And Resistance For INCY Stock
The 24-hour chart illustrates a support level at 64.17, which if violated will result in even more drops to 63.02. On the upside, there is a resistance level at 66.21. A further resistance level may holdings at 67.11. The Relative Strength Index (RSI) on the 14-day chart is 60.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.37, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.36%. Stochastics %K at 88.92% indicates the stock is a selling.
The most recent change occurred on October 01, 2024 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $84 price target.
